Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.

Health
By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3tZVqr6
via IFTTT

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda